These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 36853831)
1. Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models. Li X; Li Y; Dong L; Chang Y; Zhang X; Wang C; Chen M; Bo X; Chen H; Han W; Nie J J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36853831 [TBL] [Abstract][Full Text] [Related]
2. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 Wang K; Coutifaris P; Brocks D; Wang G; Azar T; Solis S; Nandi A; Anderson S; Han N; Manne S; Kiner E; Sachar C; Lucas M; George S; Yan PK; Kier MW; Laughlin AI; Kothari S; Giles J; Mathew D; Ghinnagow R; Alanio C; Flowers A; Xu W; Tenney DJ; Xu X; Amaravadi RK; Karakousis GC; Schuchter LM; Buggert M; Oldridge D; Minn AJ; Blank C; Weber JS; Mitchell TC; Farwell MD; Herati RS; Huang AC Cancer Cell; 2024 Sep; 42(9):1582-1597.e10. PubMed ID: 39214097 [TBL] [Abstract][Full Text] [Related]
3. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376 [TBL] [Abstract][Full Text] [Related]
4. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors. Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. Stelekati E; Chen Z; Manne S; Kurachi M; Ali MA; Lewy K; Cai Z; Nzingha K; McLane LM; Hope JL; Fike AJ; Katsikis PD; Wherry EJ Cell Rep; 2018 May; 23(7):2142-2156. PubMed ID: 29768211 [TBL] [Abstract][Full Text] [Related]
6. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. Chen Z; Ji Z; Ngiow SF; Manne S; Cai Z; Huang AC; Johnson J; Staupe RP; Bengsch B; Xu C; Yu S; Kurachi M; Herati RS; Vella LA; Baxter AE; Wu JE; Khan O; Beltra JC; Giles JR; Stelekati E; McLane LM; Lau CW; Yang X; Berger SL; Vahedi G; Ji H; Wherry EJ Immunity; 2019 Nov; 51(5):840-855.e5. PubMed ID: 31606264 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive profile of TCF1 Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298 [TBL] [Abstract][Full Text] [Related]
8. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533 [TBL] [Abstract][Full Text] [Related]
9. Progenitor-like exhausted SPRY1 Liu Z; Zhang Y; Ma N; Yang Y; Ma Y; Wang F; Wang Y; Wei J; Chen H; Tartarone A; Velotta JB; Dayyani F; Gabriel E; Wakefield CJ; Kidane B; Carbonelli C; Long L; Liu Z; Su J; Li Z Cancer Cell; 2023 Nov; 41(11):1852-1870.e9. PubMed ID: 37832554 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Pauken KE; Sammons MA; Odorizzi PM; Manne S; Godec J; Khan O; Drake AM; Chen Z; Sen DR; Kurachi M; Barnitz RA; Bartman C; Bengsch B; Huang AC; Schenkel JM; Vahedi G; Haining WN; Berger SL; Wherry EJ Science; 2016 Dec; 354(6316):1160-1165. PubMed ID: 27789795 [TBL] [Abstract][Full Text] [Related]
12. Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer. Xu Y; Wang H; Wang T; Chen C; Sun R; Yao W; Ma Y; Zhang Q; Wu L; Zeng S; Sun X Cancer Sci; 2022 May; 113(5):1739-1751. PubMed ID: 35238098 [TBL] [Abstract][Full Text] [Related]
13. CD4 Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy. Liu Z; Li X; Gao Y; Liu J; Feng Y; Liu Y; Wang J; Wang C; Wang D; He J; Han W; Mei Q; Sun Y Mol Cancer; 2023 May; 22(1):84. PubMed ID: 37189103 [TBL] [Abstract][Full Text] [Related]
15. The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8 Baxter AE; Huang H; Giles JR; Chen Z; Wu JE; Drury S; Dalton K; Park SL; Torres L; Simone BW; Klapholz M; Ngiow SF; Freilich E; Manne S; Alcalde V; Ekshyyan V; Berger SL; Shi J; Jordan MS; Wherry EJ Immunity; 2023 Jun; 56(6):1320-1340.e10. PubMed ID: 37315535 [TBL] [Abstract][Full Text] [Related]
19. CD8 Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S Front Immunol; 2021; 12():715234. PubMed ID: 34354714 [TBL] [Abstract][Full Text] [Related]
20. Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8 Li S; Li K; Wang K; Yu H; Wang X; Shi M; Liang Z; Yang Z; Hu Y; Li Y; Liu W; Li H; Cheng S; Ye L; Yang Y Nat Commun; 2023 Nov; 14(1):7709. PubMed ID: 38001101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]